Professional
Added to YB: 2023-12-12
Pitch date: 2023-12-12
BAX [bullish]
Baxter International Inc.
-44.06%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Market Cap
$9.3B
Pitch Price
$34.91
Price Target
67.00 (+250%)
Dividend
0.22%
EV/EBITDA
7.79
P/E
-26.24
EV/Sales
1.57
Sector
Health Care Equipment and Supplies
Category
special_situation
Show full summary:
Baxter International Inc.: Easing Pressures Should Boost Baxter's Prospects, Especially in 2025 and Beyond
$BAX: External pressures easing, financial prospects improving especially 2025+ as hospitals renegotiate reimbursement & key contracts. Spinoff kidney care by mid-24, focus on profit growth in other biz. Narrow moat on dialysis & injectables. FVE $67, 24x '24 EPS, 3% rev 7% EPS CAGR '22-27.
Read full article (9 min)